Neuren Pharmaceuticals (ASX: NEU) Share Price

NEU

$13.39▲+0.60%

$1.69BRank #249 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$1.69B

Volume

300K

P/E Ratio

38.25

EPS

$0.1216

Dividend Yield

0.00%

52-Week High

$22.985

52-Week Low

$11.00

Beta

1.591

Neuren Pharmaceuticals (ASX: NEU) is an Australian-listed company in the Healthcare sector with a market capitalisation of $1.69B and the 249th-largest security on the ASX by market capitalisation. The NEU share price is $13.39, up 0.60% today and down 3.31% over the past 12 months. Shares have traded between $11.00 and $22.985 over the past 52 weeks. NEU trades on a price-to-earnings ratio of 38.25, above the Healthcare sector median of 14.96. In its most recent reported period (ending 31 Dec 2025), Neuren Pharmaceuticals reported revenue of $36.4M and a net profit of $15.4M (42.4% margin).

Charts

$13.44

24H Range

$13.39

$13.76

52-Week Range

$11.00

$22.985

About Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Limited, an Australian biopharmaceutical firm, is dedicated to developing innovative treatments for neurological conditions. Its leading drug candidate, trofinetide, is currently in advanced (Phase III) clinical trials for Rett syndrome, following its successful completion of Phase II trials for Fragile X syndrome. The company is also progressing with NNZ-2591, which has finished its initial Phase I clinical studies for several disorders, including Phelan-McDermid, Angelman, Pitt Hopkins, and Prader-Will syndromes. Beyond its therapeutic pipeline, Neuren Pharmaceuticals provides development services and holds loan-funded shareholdings. The company was founded in 2001 and operates from Camberwell, Australia.

IPO Date

1 Feb 2005

CEO

Jonathan Charles Pilcher

Employees

Website

neurenpharma.com

Key Financial Data

Revenue (Quarterly)	$36.4M
Net Income (Quarterly)	$15.4M
Total Assets	$342.9M
Total Debt	$0
Free Cash Flow	$-2.9M
Return on Equity	4.55%
Profit Margin	42.37%
Operating Margin	30.60%

NEU Frequently Asked Questions

What is the Neuren Pharmaceuticals (ASX: NEU) share price?

The NEU share price is $13.39, up 0.60% for the day, based on the latest available ASX market data.

What is Neuren Pharmaceuticals's market capitalisation?

Neuren Pharmaceuticals has a market capitalisation of $1.69B, making it the 249th-largest security listed on the ASX.

Does Neuren Pharmaceuticals pay a dividend?

NEU does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

What is NEU's P/E ratio?

Neuren Pharmaceuticals trades on a trailing price-to-earnings (P/E) ratio of 38.25, based on its current share price and most recent reported earnings.

Is Neuren Pharmaceuticals profitable?

Yes. In its most recent reported period (ending 31 Dec 2025), NEU reported revenue of $36.4M and a net profit of $15.4M.

How many NEU shares are on issue?

Neuren Pharmaceuticals has approximately 126,323,976 shares on issue, based on its market capitalisation of $1.69B and current share price.

What sector is Neuren Pharmaceuticals in?

Neuren Pharmaceuticals is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Neuren Pharmaceuticals list on the ASX?

Neuren Pharmaceuticals listed on the Australian Securities Exchange on 1 Feb 2005.

Latest News

Is Neuren (ASX:NEU) Stock Worth Watching After Its Latest DAYBUE Update?

Kalkine27 May 2026

Is Neuren (ASX:NEU) Stock Worth Watching After Its Latest DAYBUE Update? Kalkine

Slammed 30% Neuren Pharmaceuticals Limited (ASX:NEU) Screens Well Here But There Might Be A Catch

simplywall.st5 Feb 2026

Slammed 30% Neuren Pharmaceuticals Limited (ASX:NEU) Screens Well Here But There Might Be A Catch simplywall.st

Neuren Pharmaceuticals Limited (ASX: NEU) - Share Price

intelligentinvestor.com.au28 Sept 2025

Neuren Pharmaceuticals Limited (ASX: NEU) - Share Price intelligentinvestor.com.au

Neuren Pharmaceuticals Limited (ASX:NEU) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Yahoo Finance12 Jan 2026

Neuren Pharmaceuticals Limited (ASX:NEU) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? Yahoo Finance

Neuren Pharmaceuticals Q1 2026: DAYBUE sales soar

The Motley Fool Australia7 May 2026

Neuren Pharmaceuticals Q1 2026: DAYBUE sales soar The Motley Fool Australia

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
MSBMesoblast Limited	$2.52B	$1.95	0.00	0.00%	▼-1.02%
REGRegis Healthcare Limited	$1.80B	$5.95	39.00	1.17%	▼-1.16%
SNZSummerset Group Holdings Limited	$1.68B	$6.93	5.59	0.47%	▼-0.57%
CU6Clarity Pharmaceuticals Ltd	$801.9M	$2.15	-5.54	0.00%	▲+4.37%
PYCPYC Therapeutics Limited	$711.3M	$1.22	-10.86	0.00%	▲+3.39%
CUVClinuvel Pharmaceuticals Limited	$451.7M	$8.96	14.96	0.40%	▲+1.24%
ATHAlterity Therapeutics Limited	$107.7M	$0.495	-2.12	0.00%	▲+11.24%
IMMImmutep Limited	$69.3M	$0.047	-3.40	0.00%	–+0.00%

ETFs That Hold NEU

NEU is held by 10 ASX-listed funds tracked on this site. The largest allocation is in iShares S&P/ASX Small Ordinaries ETF (ASX: ISO) at 0.52% of its portfolio.

Fund	Portfolio Weight	Fund Size
ISOiShares S&P/ASX Small Ordinaries ETF	0.52%	$134.5M
VSOVanguard MSCI Australian Small Companies Index ETF	0.34%	$1.18B
FAIRBetaShares - Australian Sustainability Leaders ETF	0.29%	$1.10B
EX20BetaShares - Australian Ex-20 Portfolio Diversifier ETF	0.14%	$662.3M
IJHiShares S&P Mid-Cap ETF	0.14%	$487.8M
VASVanguard Australian Shares Index ETF	0.08%	$26.10B
AUSTBetaShares - Managed Risk Australian Shares Complex ETF	0.06%	$33.0M
IOZiShares Core S&P/ASX 200 ETF	0.06%	$8.88B
VISMVanguard MSCI International Small Companies Index ETF	0.05%	$906.8M
A200BetaShares - Australia 200 ETF	0.05%	$10.05B

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$13.60	$13.76	$13.39	$13.44	246K	▲+0.98%
11 June 2026	$13.06	$13.42	$12.99	$13.31	157K	▲+0.15%
10 June 2026	$13.30	$13.56	$13.02	$13.29	143K	▼-1.26%
9 June 2026	$13.38	$13.56	$13.02	$13.46	198K	▼-1.39%
8 June 2026	$13.73	$13.85	$13.48	$13.65	175K	▼-0.07%
5 June 2026	$13.73	$13.85	$13.48	$13.66	121K	▲+1.19%
4 June 2026	$13.44	$13.75	$13.32	$13.50	144K	▼-0.52%
3 June 2026	$13.61	$13.715	$12.52	$13.57	392K	▼-0.95%
2 June 2026	$14.11	$14.36	$13.365	$13.70	258K	▼-3.52%
1 June 2026	$14.24	$14.58	$13.97	$14.20	178K	▼-1.93%
29 May 2026	$14.00	$14.52	$13.82	$14.48	170K	▲+5.08%
28 May 2026	$13.65	$13.99	$13.56	$13.78	203K	▼-0.22%
27 May 2026	$14.70	$14.71	$13.05	$13.81	330K	▼-4.50%
26 May 2026	$14.49	$14.72	$14.13	$14.46	203K	▼-0.07%
25 May 2026	$13.80	$14.55	$13.73	$14.47	383K	▲+6.16%
22 May 2026	$13.05	$13.70	$12.95	$13.63	286K	▲+4.69%
21 May 2026	$12.89	$13.10	$12.57	$13.02	281K	▲+4.92%
20 May 2026	$12.62	$12.81	$12.33	$12.41	116K	▼-1.27%
19 May 2026	$12.63	$12.70	$12.49	$12.57	200K	▲+1.95%
18 May 2026	$12.74	$13.03	$12.29	$12.33	214K	▼-3.60%
15 May 2026	$12.89	$13.12	$12.75	$12.79	146K	▼-0.08%
14 May 2026	$12.72	$12.96	$12.48	$12.80	179K	▲+0.63%
13 May 2026	$12.67	$12.85	$12.31	$12.72	345K	▼-1.09%
12 May 2026	$13.11	$13.16	$12.55	$12.86	389K	▼-4.39%
11 May 2026	$12.76	$13.45	$12.36	$13.45	373K	▲+5.16%
8 May 2026	$12.77	$13.31	$12.58	$12.79	433K	▼-1.31%
7 May 2026	$12.69	$13.33	$12.55	$12.96	521K	▲+5.41%
6 May 2026	$12.65	$12.685	$12.27	$12.295	119K	▼-1.24%
5 May 2026	$12.33	$12.63	$12.26	$12.45	185K	▼-0.88%
4 May 2026	$12.55	$12.77	$12.265	$12.56	155K	▲+0.64%